2022
DOI: 10.3390/app12031373
|View full text |Cite
|
Sign up to set email alerts
|

BMP-2 Delivery through Liposomes in Bone Regeneration

Abstract: Bone regeneration is a central focus of maxillofacial research, especially when dealing with dental implants or critical sized wound sites. While bone has great regeneration potential, exogenous delivery of growth factors can greatly enhance the speed, duration, and quality of osseointegration, making a difference in a patient’s quality of life. Bone morphogenic protein 2 (BMP-2) is a highly potent growth factor that acts as a recruiting molecule for mesenchymal stromal cells, induces a rapid differentiation o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
7
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 128 publications
(126 reference statements)
0
7
0
Order By: Relevance
“…For instance, the delivery of genes encoding osteogenic growth factors, such as TGF-B and BMP, is becoming one of the clinically relevant applications for bone regeneration. These strategies can help initiate progenitor cell differentiation and regulate the pathways related to stimulating new bone formation and maturation [ 169 ]. It has been reported that the microtubule-stabilizing agent paclitaxel (PTX) can reduce scarring and improve axon regeneration following spinal cord injury.…”
Section: Drug Delivery Systemsmentioning
confidence: 99%
“…For instance, the delivery of genes encoding osteogenic growth factors, such as TGF-B and BMP, is becoming one of the clinically relevant applications for bone regeneration. These strategies can help initiate progenitor cell differentiation and regulate the pathways related to stimulating new bone formation and maturation [ 169 ]. It has been reported that the microtubule-stabilizing agent paclitaxel (PTX) can reduce scarring and improve axon regeneration following spinal cord injury.…”
Section: Drug Delivery Systemsmentioning
confidence: 99%
“…In vivo, a study on pigs where calvarial bone defects were created and revealed completely with the application of liposome/BMP-2 carrier. [132] Gene-activated matrix (GAM) gives an available method to address the limitation of short half-life and easy degeneration in growth factors materials. A novel GAM system (PEI/pBMP-2-HA/CS-MS) composed of PEI/pBMP-2 and hydroxyapatite/ chitosan-microspheres (HA/CS-MS) has an intensive bone regeneration capacity.…”
Section: Plasmidmentioning
confidence: 99%
“…PEI/pBMP-2-HA/CS-MS promotes the angiogenic and osteogenic function of BMSCs. [132,133] Plasmid DNA encoding TGF-β1 induced BMSCs differentiating into chondrocytes. Plasmid DNA encoding TGF-β1 encapsulated in chitosan gelatin complexes further enhanced cartilage repair.…”
Section: Dna Aptamermentioning
confidence: 99%
“…Liposomes protect their core contents through a hydrated phospholipid bilayer and provide protection against both hydrophobic and hydrophilic drugs [ 107 ]. The use of liposome-loaded EGF has long been shown to promote bone regeneration in the rat alveolus [ 108 ], and there have also been many studies focusing on the delivery of BMP-2 in liposomes [ 109 ]. Li et al synthesized a non-phospholipid liposome nanoparticle and loaded a smoothened agonist into the nanoparticle, which was then modified by coating the surface of the bone implant.…”
Section: Exogenous Growth Factor Deliverymentioning
confidence: 99%